A statistical information site that deepens
the understanding of AMR (drug resistance) and one health

MENU

A statistical information site that deepens the understanding of AMR (drug resistance) and one health

JP EN

References

  1. [1] Ministerial Conference for the Control of Globally Threatening Infectious Diseases. “The National Action Plan on Antimicrobial Resistance (AMR)2016-2020.” 2017.
  2. [2] Muraki Y, et al.“Japanese antimicrobial consumption surveillance: first report on oral and parenteral antimicrobial consumption in Japan(2009–2013)” J Glob Antimicrob Resist. 2016 Aug 6;7:19-23.
  3. [3] National Center for Global Health and Medicine. Website of the AMR Clinical Reference Center. Surveillance of Antimicrobial Use by Prefecture and Age Group Based on the National Database for Prescription and National Health Check-up (NDB). (published October 30, 2018).
    http://amrcrc.ncgm.go.jp/surveillance/index.html.
  4. [4] Konishi N, et al. “ ‘Epidemiological Research concerning Antimicrobial-resistant Enteric Bacteria Derived from Humans and from Food,’ Shared Research under ‘Research concerning Trends and Hygienic Control of Antimicrobial-resistant Bacteria Derived from Food’, Shared Research Report, Grants for Research from the Ministry of Health, Labour and Welfare of Japan) (Research Project concerning the Assurance and Promotion of Food Safety) FY2016.” 2018.
  5. [5] Shinomiya H, et al. “ ‘Establishment of Information Collection Systems concerning Antimicrobial-resistant Bacteria Isolated at Public Health Institutes across Japan,’ Shared Research under ‘Research concerning Trends and Hygienic Control of Antimicrobial-resistant Bacteria Derived from Food,’ Shared Research Report, Grants for Research from the Ministry of Health, Labour and Welfare of Japan) (Research Project concerning the Assurance and Promotion of Food Safety) FY2016.” 2018.
  6. [6] Ministry of Health, Labour and Welfare. Japan Nosocomial Infections Surveillance. “SSI Division, JANIS Term Report and Annual Report (for the General Public).” from https://janis.mhlw.go.jp/report/ssi.html
  7. [7] Ministry of Health, Labour and Welfare. Japan Nosocomial Infections Surveillance. “ICU Division, JANIS Term Report and Annual Report (for the General Public).” from https://janis.mhlw.go.jp/report/icu.html
  8. [8] Galdys AL, et al. "Prevalence and duration of asymptomatic Clostridium difficile carriage among healthy subjects in Pittsburgh, Pennsylvania." J Clin Microbiol. 2014;52(7):2406-9.
  9. [9] Evans CT, et al. "Current Trends in the Epidemiology and Outcomes of Clostridium difficile Infection" Clin Infect Dis 2015; 60 (suppl_2): S66-S71.
  10. [10] T. V. Riley, T. Kimura.” The Epidemiology of Clostridium difficile Infection in Japan : A Systematic Review” Infect Dis Ther. 2018;7:39–70.
  11. [11] Honda H, et al. “Epidemiology of Clostridium difficile infections in Japan” Abst. No.2071 ID Week 2016, New Orleans, LA.
  12. [12] Vaz-Moreira I, Nunes OC, Manaia CM. “Bacterial diversity and antibiotic resistance in water habitats: searching the links with the human microbiome.” FEMS Microbiol Rev 2014; 38(4): 761-78.
  13. [13] Bengtsson-Palme J, et al. “Shotgun metagenomics reveals a wide array of antibiotic resistance genes and mobile elements in a polluted lake in India.” Front Microbiol 2014; 5: 648.
  14. [14] Laht M, et al. “Abundances of tetracycline, sulphonamide and beta-lactam antibiotic resistance genes in conventional wastewater treatment plants (WWTPs) with different waste load.” PLoS One 2014; 9(8): e103705.
  15. [15] Amos GC, et al.“ Validated predictive modelling of the environmental resistome” ISME J 2015; 9(6): 1467-76.
  16. [16] "Impacts of Pharmaceutical Pollution on Communities and Environment in India. " February 2016. https://www.nordea.com/Images/37107450/2016%2004_Nordea%20report_final_web_single%20page%20small.pdf
  17. [17] van Hoek AH, et al. "Prevalence and characterization of ESBL- and AmpC-producing Enterobacteriaceae on retail vegetables,"Int J Food Microbiol. 2015 Jul 2;204:1-8.
  18. [18] Leonard AFC, et al. "Exposure to and colonisation by antibiotic-resistant E. coli in UK coastal water users: Environmental surveillance, exposure assessment, and epidemiological study (Beach Bum Survey),” Environ Int. 2018 May;114:326-333.
  19. [19] Paschoal RP et al. "Concentration and Variety of Carbapenemase Producers in Recreational Coastal Waters Showing Distinct Levels of Pollution," Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01963-17
  20. [20] "Global Sewage Surveillance Project." http://www.compare-europe.eu/library/global-sewage-surveillance-project
  21. [21] Gomi R et al. "Characteristics of Carbapenemase-Producing Enterobacteriaceae in Wastewater Revealed by Genomic Analysis,” Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02501-17.
  22. [22] Sekizuka T et al. "Complete Genome Sequence of a blaKPC-2-Positive Klebsiella pneumoniae Strain Isolated from the Effluent of an Urban Sewage Treatment Plant in Japan,” mSphere. 2018 Sep 19;3(5). pii: e00314-18.
  23. [23] "Environmental Dimensions of AMR workshop." http://www.jpiamr.eu/activities/environmental-dimensions-of-amr-workshop/
  24. [24] ResistanceMap. The Center for Disease Dynamics, Economic & Policy. Available from https://resistancemap.cddep.org/AntibioticUse.php
  25. [25] Tanaka H, et al. “Contamination of the Aquatic Environment by PPCPs, and Development of Reducing Technology.” Environmental Technology, Vo. 37, No. 12., 2008.
  26. [26] Park J, et al. “Removal characteristics of PPCPs: comparison between membrane bioreactor and various biological treatment process.” Chemosphere. 2017; 179: 347e358.
  27. [27] Narumiya M, et al. “Phase distribution and removal of PPCPs during anaerobic sludge digestion” Journal of Hazardous Materials 2013; 260: 305 - 312.
  28. [28] Azuma T, et al. “Evaluation of concentrations of pharmaceuticals detected in sewage influents in Japan by using annual shipping and sales data” Chemosphere. 2015;138 :770 -776.
  29. [29] Ohmagari N, et al. “ ‘Research on the Public Awareness concerning Antimicrobial Resistance’, under ‘Research concerning the Infection Control of Antimicrobial-Resistant Bacteria in Medical Institutions’ (2016-Emg-Adm-General-003), Shared Research Report, Grants for Research from the Ministry of Health, Labour and Welfare of Japan) (Research Project concerning Emerging and Re-emerging Infectious Diseases and Vaccination Policies) FY2016.” 2017
  30. [30] Ohmagari N, et al. “ ‘Research on the Public Awareness concerning Antimicrobial Resistance’, under ‘Research concerning the Infection Control of Antimicrobial-Resistant Bacteria in Medical Institutions’ (2016-Emg-Adm-General-003), Shared Research Report, Grants for Research from the Ministry of Health, Labour and Welfare of Japan) (Research Project concerning Emerging and Re-emerging Infectious Diseases and Vaccination Policies) FY2016.” 2018
  31. [31] Nakahama T. “Present Status of the Use of Oral Antimicrobials in Outpatient Units.” Clinical Medicine and Microbiology. Vol. 44, No. 4, 2017.
  32. [32] Gu Y, et al. “ ‘A Study of Techniques for Promoting and Encouraging the Proper Use of Antimicrobials in Outpatient Units’, under ‘Research concerning the Infection Control of Antimicrobial-Resistant Bacteria in Medical Institutions through Regional Collaboration’ (2016-Emg-Adm-General-004), Shared Research Report, Grants for Research from the Ministry of Health, Labour, and Welfare of Japan) (Research Project concerning Emerging and Re-emerging Infectious Diseases and Vaccination Policies) FY2017”.
  33. [33] World Health Organization.“Global Antimicrobial Resistance Surveillance System. Manual for Early implementation" http://www.who.int/antimicrobial-resistance/publications/surveillance-system-manual/en/
  34. [34] National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries. “Monitoring of AMR.” Accessed on August 1st, 2017, from http://www.maff.go.jp/nval/yakuzai/yakuzai_p3.html
  35. [35] "Monitoring of the Quantities and Usage patterns of Antimicrobial Agents Used in Food-Producing Animal" http://www.oie.int/fileadmin/Home/eng/Health_standards/tahc/current/chapitre_antibio_monitoring.pdf
  36. [36] "Harmonisation of National Antimicrobial Resistance Surveillance and Monitoring Programmes." http://www.oie.int/fileadmin/Home/eng/Health_standards/tahc/current/chapitre_antibio_harmonisation.pdf
  37. [37] National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries. “Antibiograms of Escherichia coli Surveyed under JVARM.” from http://www.maff.go.jp/nval/yakuzai/yakuzai_p3-1.html
  38. [38] Hiki M, et al. “Decreased Resistance to Broad-Spectram Cephalosporin in Escherichia coli from Healthy Broilers at Farms in Japan After Voluntary Withdrawal of Ceftiofur,” Foodborne Pathogens Dis. 2015; 12:639-643.
  39. [39] Nakayama SI, et al. “New ceftriaxone- and multidrug-resistant Neisseria gonorrhoeae strain with a novel mosaic penA gene isolated in Japan,” Antimicrob Agents Chemorher 2016; 60; 4339-4341.
  40. [40] Lahra MM, et al. “Cooperative recognition of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain,” Emerg Infect Dis 2018; 24; 735-740.

Websites of Key Trend Surveys